123 related articles for article (PubMed ID: 19789365)
1. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.
Rejnmark L; Tietze A; Vestergaard P; Buhl L; Lehbrink M; Heickendorff L; Mosekilde L
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2655-60. PubMed ID: 19789365
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.
Yao S; Sucheston LE; Millen AE; Johnson CS; Trump DL; Nesline MK; Davis W; Hong CC; McCann SE; Hwang H; Kulkarni S; Edge SB; O'Connor TL; Ambrosone CB
PLoS One; 2011 Feb; 6(2):e17251. PubMed ID: 21386992
[TBL] [Abstract][Full Text] [Related]
3. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study.
Almquist M; Bondeson AG; Bondeson L; Malm J; Manjer J
Int J Cancer; 2010 Nov; 127(9):2159-68. PubMed ID: 20112341
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.
Jamshidinaeini Y; Akbari ME; Abdollahi M; Ajami M; Davoodi SH
J Am Coll Nutr; 2016; 35(7):639-646. PubMed ID: 27331363
[TBL] [Abstract][Full Text] [Related]
7. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study.
Bertone-Johnson ER; Hankinson SE; Forger NG; Powers SI; Willett WC; Johnson SR; Manson JE
BMC Womens Health; 2014 Apr; 14():56. PubMed ID: 24725979
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
9. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
11. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy.
Rejnmark L; Lauridsen AL; Brot C; Vestergaard P; Heickendorff L; Nexo E; Mosekilde L
Scand J Clin Lab Invest; 2006; 66(3):227-38. PubMed ID: 16714251
[TBL] [Abstract][Full Text] [Related]
13. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency.
Hatse S; Lambrechts D; Verstuyf A; Smeets A; Brouwers B; Vandorpe T; Brouckaert O; Peuteman G; Laenen A; Verlinden L; Kriebitzsch C; Dieudonné AS; Paridaens R; Neven P; Christiaens MR; Bouillon R; Wildiers H
Carcinogenesis; 2012 Jul; 33(7):1319-26. PubMed ID: 22623648
[TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
Kühn T; Kaaks R; Becker S; Eomois PP; Clavel-Chapelon F; Kvaskoff M; Dossus L; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Lukanova A; Buijsse B; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Krogh V; Sacerdote C; Tumino R; Mattiello A; Buckland G; Sánchez MJ; Menéndez V; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; van Duijnhoven FJ; van Gils CH; Bakker MF; Weiderpass E; Skeie G; Brustad M; Andersson A; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Rinaldi S; Romieu I; Gallo V; Murphy N; Riboli E; Linseisen J
Int J Cancer; 2013 Oct; 133(7):1689-700. PubMed ID: 23526380
[TBL] [Abstract][Full Text] [Related]
16. Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women.
Green AK; Hankinson SE; Bertone-Johnson ER; Tamimi RM
Int J Cancer; 2010 Aug; 127(3):667-74. PubMed ID: 19960434
[TBL] [Abstract][Full Text] [Related]
17. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
18. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.
Yao S; Kwan ML; Ergas IJ; Roh JM; Cheng TD; Hong CC; McCann SE; Tang L; Davis W; Liu S; Quesenberry CP; Lee MM; Ambrosone CB; Kushi LH
JAMA Oncol; 2017 Mar; 3(3):351-357. PubMed ID: 27832250
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
20. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum.
Mohr SB; Gorham ED; Alcaraz JE; Kane CI; Macera CA; Parsons JK; Wingard DL; Horst R; Garland CF
Cancer Causes Control; 2013 Mar; 24(3):495-504. PubMed ID: 23296455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]